(Total Views: 485)
Posted On: 06/28/2020 8:30:18 AM
Post# of 36566
I have been contemplating my personal situation a lot these last few months. Too much time on my hands with CV-19 slowing things up a bit.
My birthday is in August. For quite sometime I planned on retiring between then and the end of the year. I have steadily worked towards that goal, eliminating debt etc. Generex was expected to be the investment that put me in a retire "quite comfortably" category. A year ago that looked like a sure thing. Then things started unraveling. We don't need a review of those events. Then CV-19 hit.
As you know I own a good number of shares. I had taken a purchasing break for a bit. Since the 8-k's started coming out steadily and based on my communication with others, I added to my position a bit. Given that I still hope to retire or at least slow down by years end I probably SHOULD stop adding more risk in my portfolio. Having said that, with financing in order for GNBT/NGIO, I consider anything between 50 cents and $1.50 a bargain and would buy whatever amount my investment plan allows for a speculative biotech company.
My birthday is in August. For quite sometime I planned on retiring between then and the end of the year. I have steadily worked towards that goal, eliminating debt etc. Generex was expected to be the investment that put me in a retire "quite comfortably" category. A year ago that looked like a sure thing. Then things started unraveling. We don't need a review of those events. Then CV-19 hit.
As you know I own a good number of shares. I had taken a purchasing break for a bit. Since the 8-k's started coming out steadily and based on my communication with others, I added to my position a bit. Given that I still hope to retire or at least slow down by years end I probably SHOULD stop adding more risk in my portfolio. Having said that, with financing in order for GNBT/NGIO, I consider anything between 50 cents and $1.50 a bargain and would buy whatever amount my investment plan allows for a speculative biotech company.
(5)
(0)
